Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Bayer ( (DE:BAYN) ) is now available.
Bayer Aktiengesellschaft announced a managerial transaction involving Dr. Nancy Simonian, a member of the administrative or supervisory body, who purchased shares as part of the Board of Management’s commitment to buy Bayer AG shares. The transaction, executed on March 11, 2025, at the Frankfurt Stock Exchange, involved a total volume of 36,293.88 USD at a price of 25.9242 USD per share, reflecting the company’s ongoing efforts to align management interests with shareholder value.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of health care and agriculture. The company develops and manufactures products that serve the pharmaceutical, consumer health, and crop science markets, focusing on innovation and sustainability.
YTD Price Performance: 21.52%
Average Trading Volume: 741,562
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €23.22B
See more insights into BAYN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue